The Enserink group at Cancell arranged a first meeting with three user representatives for our leukemia research on January 12th 2018. This half-day meeting included presentations of and discussions around some of our current leukemia research projects. We also enjoyed a nice lunch together and had time for a visit to the laboratory, including the fruit fly facilities and the cell lab.
A meaningful highlight of this first meeting was that user representatives shared their experience of getting diagnosed with leukemia, undergoing treatment and dealing with undesirable side-effects and relapse. Hearing these stories was both moving and inspiring for us to continue our research at CanCell to provide better treatment options for leukemia in the future.